BH vs GIII

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and the absence of an Altman Z-Score prevents a full distress risk assessment. Despite strong recent price performance (+110.4% over 1Y), the stock trades at an extremely high P/E of 217.27 versus negative Forward P/E, signaling earnings deterioration. Profitability metrics are concerning, with a mere 0.54% net margin and 0.35% ROE, well below sector averages. While the balance sheet shows a healthy current ratio and low Price/Book of 0.50, these are overshadowed by unsustainable valuation and weak earnings momentum.

GIII presents a classic value trap profile: strong balance sheet health but deteriorating growth. The Piotroski F-Score of 4/9 indicates stable but non-improving financial health, while the Graham Number of $37.65 suggests the stock is undervalued relative to its assets. However, this is offset by alarming growth metrics, including a -76.4% YoY EPS decline and negative revenue growth. While the low Debt/Equity (0.16) and high Current Ratio (2.69) provide a significant safety floor, the lack of growth and bearish insider activity temper the bullish value case.